Oncovalent Therapeutics
Thousand Oaks · Founded 2013
About Oncovalent Therapeutics
Developer of Immuno oncology drugs intended to develop novel therapeutics to inhibit the human oncogene. The company develops small molecule drugs that are orally available and straightforward to synthesize used for aggressive lymphoma and colorectal cancers, thereby providing clients with products to address unmet medical needs.
Company Facts
- Founded: 2013
- Legal name: Oncovalent Therapeutics Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Last round: Undisclosed (Sep 2020)
- Website: oncovalent.com
Social Profiles
Canonical: https://fsome.com/organization/oncovalent-therapeutics-8440866 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.